The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Azzalure (Galderma) is a newly approved European botulinum neurotoxin type A (BoNT‐A) specifically designed for aesthetic usages. It is sourced from Dysport (Ipsen Ltd.), which has a 20‐year product consistency and has been used widely for various therapeutic and aesthetic applications. Azzalure and Dysport are collectively referred to as BoNT‐A (Speywood Unit; s.U) (or abobotulinumtoxinA in the U...
Objective The aim of this study was to determine the prevalence of psoriatic arthritis (PsA) in the patients with plaque psoriasis and to give recommendation for the diagnosis of PsA for dermatologists.
Methods A systematic search was performed in Pubmed, Cochrane and Embase databases. The key‐words used from the Medical Searching Heading (MeSH) were: ‘Psoriasis’, ‘Arthritis, Psoriatic’, ‘Uveitis’...
Background Severity of psoriasis appears to be multidimensional and its assessment in everyday clinical practice requires a complex holistic approach.
Objectives To develop evidence‐based recommendations to assess severity of plaque‐type psoriasis in adult patients in everyday clinical practice.
Methods A scientific committee (10 members identified on the basis of their expertise in psoriasis)...
Background A wide variety of scoring systems have been proposed to assess severity of psoriasis. Given its importance as a health issue both for patients and health care systems, it is critically important to evaluate the validity and reliability of existing outcome measures.
Objective The objective of this systematic review was to assess the extent of validation including the validity, reliability,...
Introduction Many epidemiological studies have associated psoriasis with an increased risk of coronary artery disease, resulting from a higher prevalence of cardiovascular risk factors in psoriasis patients compared with unmatched controls. However, the results of epidemiological studies vary depending upon the populations studied. The aim of this systemic review was to evaluate the risk of diabetes,...
Background The assessment of health‐related quality of life (QOL) is important in psoriasis. Despite this, among the wide variety of QOL questionnaires used in psoriasis, there is no consensus as to which is the best.
Objective The objective of this systematic review was to identify which of these measurements have acceptable evaluation criteria for both monitoring disease and research purposes...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.